Skip to Main ContentSkip to FooterSkip to Search
Contact Us
Contact Us
  1. Home
    2.  » 
  2. Expert Content
    3.  » 
  3. Cell Therapy
    4.  » Advancing Towards a Universal Platform for iPSC-Based Therapies

Advancing Towards a Universal Platform for iPSC-Based Therapies: An Interview with Boris Greber

Summary:  Human induced pluripotent stem cells (iPSCs) enable availability of next-generation cell therapies for broader patient population at a faster turnaround time for a variety of disease areas. Catalent iPSC expert Boris Greber discusses the use of iPSCs as starting materials for cellular therapies, including the concept behind a universal platform for iPSC-based therapies.

Click here to download the Article

Contact Us